Adamantan-1-yl-[1-(5-fluoro-pentyl)-1H-indol-3-yl]-methanone

ID: ALA4472271

Cas Number: 1364933-62-9

PubChem CID: 91885143

Max Phase: Preclinical

Molecular Formula: C24H30FNO

Molecular Weight: 367.51

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(c1cn(CCCCCF)c2ccccc12)C12CC3CC(CC(C3)C1)C2

Standard InChI:  InChI=1S/C24H30FNO/c25-8-4-1-5-9-26-16-21(20-6-2-3-7-22(20)26)23(27)24-13-17-10-18(14-24)12-19(11-17)15-24/h2-3,6-7,16-19H,1,4-5,8-15H2

Standard InChI Key:  WBLLMFXPGHZFFP-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 27 31  0  0  0  0  0  0  0  0999 V2000
   33.7103  -17.4226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8132  -17.1834    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.1369  -16.8260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.7090  -16.4395    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0484  -16.0273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1967  -15.8738    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.3978  -17.2259    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5593  -17.0505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1211  -17.5600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4793  -16.2525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3155  -18.2547    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.3144  -19.0742    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0224  -19.4832    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.0206  -17.8458    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7292  -18.2511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   29.7295  -19.0697    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5081  -19.3225    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   30.9892  -18.6600    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.5077  -17.9979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7600  -17.2207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.2130  -16.6136    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   30.7609  -20.0996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.5603  -20.2693    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8130  -21.0464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6124  -21.2161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.8651  -21.9932    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6645  -22.1629    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  1  3  1  0
  2  4  1  0
  3  5  1  0
  4  6  1  0
  5  6  1  0
  7  8  1  0
  3  7  1  0
  2  9  1  0
  6 10  1  0
 10  8  1  0
  8  9  1  0
 11 12  2  0
 12 13  1  0
 13 16  2  0
 15 14  2  0
 14 11  1  0
 15 16  1  0
 16 17  1  0
 17 18  1  0
 18 19  2  0
 19 15  1  0
 19 20  1  0
 20 21  2  0
 17 22  1  0
 22 23  1  0
 20  8  1  0
 23 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
M  END

Associated Targets(non-human)

Cnr2 Cannabinoid CB2 receptor (862 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 367.51Molecular Weight (Monoisotopic): 367.2311AlogP: 6.18#Rotatable Bonds: 7
Polar Surface Area: 22.00Molecular Species: HBA: 2HBD:
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: CX LogP: 5.68CX LogD: 5.68
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.42Np Likeness Score: -0.82

References

1. Tan L, Yan W, McCorvy JD, Cheng J..  (2018)  Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.,  61  (22): [PMID:29939744] [10.1021/acs.jmedchem.8b00435]

Source